1. Home
  2. VIRC vs NYXH Comparison

VIRC vs NYXH Comparison

Compare VIRC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

N/A

Current Price

$6.27

Market Cap

97.7M

ML Signal

N/A

Logo Nyxoah SA

NYXH

Nyxoah SA

N/A

Current Price

$0.90

Market Cap

86.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIRC
NYXH
Founded
1950
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
86.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
VIRC
NYXH
Price
$6.27
$0.90
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $2.85
AVG Volume (30 Days)
22.3K
★ 247.2K
Earning Date
12-07-2026
11-05-2026
Dividend Yield
★ 1.57%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.37
N/A
Revenue
★ $199,652,000.00
N/A
Revenue This Year
N/A
$234.36
Revenue Next Year
$1.23
$98.45
P/E Ratio
$17.14
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.16
$0.80
52 Week High
$7.46
$5.92

Technical Indicators

Market Signals
Indicator
VIRC
NYXH
Relative Strength Index (RSI) 48.78 37.76
Support Level $5.93 $0.80
Resistance Level $6.50 $0.97
Average True Range (ATR) 0.17 0.05
MACD 0.00 0.02
Stochastic Oscillator 58.94 57.37

Price Performance

Historical Comparison
VIRC
NYXH

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: